• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Hill International Is Trading Higher By 15%; Here Are 30 Stocks Moving Premarket

    8/29/22 5:35:14 AM ET
    $AVCT
    $AVYA
    $BBIG
    $BGRY
    EDP Services
    Technology
    Retail: Computer Software & Peripheral Equipment
    Technology
    Get the next $AVCT alert in real time by email

    Gainers

    • NewAge, Inc. (NASDAQ:NBEV) shares rose 19.7% to $0.2432 in pre-market trading. NewAge recently received Nasdaq notice on late filing of its form 10-Q.
    • Bright Minds Biosciences Inc. (NASDAQ:DRUG) shares rose 18.1% to $3.01 in pre-market trading after declining around 12% on Friday.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) rose 16.2% to $0.1700 in pre-market trading. American Virtual Cloud Technologies shares gained around 8% on Friday after the company announced changes to its board of directors and management team, along with the launch of a review to explore the sale of the entire business or selected assets.
    • Bit Origin Limited (NASDAQ:BTOG) rose 15.1% to $0.4349 in pre-market trading after declining 10% on Friday. Bit Origin recently completed the acquisition of 622 Miners.
    • Hill International, Inc. (NYSE:HIL) rose 15% to $3.22 in pre-market trading. GISI and Hill International reported enhancements to their strategic merger agreement.
    • SPI Energy Co., Ltd. (NASDAQ:SPI) rose 13.7% to $2.24 in pre-market trading after declining 8% on Friday.
    • The OLB Group, Inc. (NASDAQ:OLB) rose 13% to $1.91 in pre-market trading after jumping 43% on Friday. OLB Group recently posted 1H sales of $17.16 million.
    • E-Home Household Service Holdings Limited (NASDAQ:EJH) rose 12.6% to $0.2399 in pre-market trading after declining around 7% on Friday.
    • Vinco Ventures, Inc. (NASDAQ:BBIG) rose 11.7% to $1.08 in pre-market trading. Vinco Ventures appointed Ross Miller as co-Chief Executive Officer along with John Colucci and Lisa King, effective immediately.
    • First High-School Education Group Co., Ltd. (NYSE:FHS) rose 11.4% to $0.78 in pre-market trading after declining more than 8% on Friday.
    • Cuentas Inc. (NASDAQ:CUEN) rose 8% to $0.74 in pre-market trading. Cuentas, in 8K Filing said on August 22, 2022, that it signed software licensing and transaction sharing agreement with The OLB Group.
    • ImmunityBio, Inc.(NASDAQ:IBRX) rose 7.6% to $4.40 in pre-market trading after declining around 8% on Friday.
    • SaverOne 2014 Ltd (NASDAQ:SVRE) rose 6.8% to $2.51 in pre-market trading.
    • Indonesia Energy Corporation Limited (NASDAQ:INDO) rose 6.3% to $10.16 in pre-market trading after gaining around 8% on Friday.


    Don’t forget to check out our premarket coverage here .

    Losers

    • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) shares fell 33.8% to $0.1348 in pre-market trading. Clarus Therapeutics recently reported its Q2 earnings results and announced it will be reducing approximately 40% of its staff in August 2022.
    • Humanigen, Inc. (NASDAQ:HGEN) shares fell 23% to $0.2161 in pre-market trading. Humanigen, said on August 24, 2022, that it received notice of delisting or failure to satisfy a continued listing rule or standard from the Nasdaq.
    • Tuesday Morning Corporation (NASDAQ:TUEM) fell 19% to $0.28 in pre-market trading after declining around 7% on Friday.
    • Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) fell 10.4% to $0.2050 in pre-market trading. Salarius Pharmaceuticals recently said Q2 EPS results were higher year over year.
    • Avaya Holdings Corp. (NASDAQ:AVYA) fell 9.9% to $1.19 in pre-market trading after dropping 13% on Friday.
    • VBI Vaccines Inc. (NASDAQ:VBIV) fell 9.7% to $0.8498 in pre-market trading. VBI Vaccines said on August 26, 2022, that the company delivered written notices to Jefferies to terminate each of July 2022 sales agreement, September 2021 sales agreement, effective Aug. 26, 2022.
    • Core Scientific, Inc. (NASDAQ:CORZ) fell 9.3% to $2.15 in pre-market trading. The company recently posted upbeat quarterly sales.
    • Chembio Diagnostics, Inc. (NASDAQ:CEMI) fell 9.2% to $0.6006 in pre-market trading. Chembio Diagnostics recently reported worse-than-expected Q2 EPS results.
    • Secoo Holding Limited (NASDAQ:SECO) fell 8.5% to $0.30 in pre-market trading. Secoo recently entered into Share Purchase Agreements with Beijing HCYK Corporation Management Partner (HCYK) and Timing Capital Limited.
    • Inhibikase Therapeutics, Inc. (NASDAQ:IKT) fell 8.5% to $0.8821 in pre-market trading. Inhibikase Therapeutics shares gained around 10% on Friday after the company announced that the FDA has reviewed its Investigational New Drug application for IkT-001Pro for the treatment of Chronic Myelogenous Leukemia and issued a Study May Procced letter.
    • Onion Global Limited (NYSE:OG) fell 8.5% to $0.4210 in pre-market trading after jumping around 18% on Friday.
    • Yatsen Holding Limited (NYSE:YSG) shares fell 7.6% to $1.22 in pre-market trading. Yatsen Holding recently posted Q2 EPADS of $(0.05).
    • Forge Global Holdings, Inc. (NYSE:FRGE) fell 7.4% to $2.90 in pre-market trading. JMP Securities, on Friday, initiated coverage on Forge Global with a Market Outperform rating and announced a price target of $10.
    • Berkshire Grey, Inc. (NASDAQ:BGRY) fell 6.1% to $2.02 in pre-market trading after dropping more than 7% on Friday.
    • Mobilicom Limited (NASDAQ:MOB) fell 5.2% to $3.13 in pre-market trading after dipping around 40% on Friday. The company recently priced its IPO at $$4.13 per unit.
    • Robinhood Markets, Inc. (NASDAQ:HOOD) fell 3.7% to $9.03 in pre-market trading after dropping around 4% on Friday.
    Get the next $AVCT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVCT
    $AVYA
    $BBIG
    $BGRY

    CompanyDatePrice TargetRatingAnalyst
    Inhibikase Therapeutics Inc.
    $IKT
    3/4/2026$4.00Buy
    Ladenburg Thalmann
    Core Scientific Inc.
    $CORZ
    3/3/2026$23.00Hold → Buy
    Needham
    Robinhood Markets Inc.
    $HOOD
    2/11/2026$135.00 → $100.00Buy
    Needham
    Robinhood Markets Inc.
    $HOOD
    2/9/2026$125.00Peer Perform → Outperform
    Wolfe Research
    Inhibikase Therapeutics Inc.
    $IKT
    1/21/2026$6.00Buy
    BofA Securities
    Robinhood Markets Inc.
    $HOOD
    1/9/2026$145.00Buy
    Argus
    Core Scientific Inc.
    $CORZ
    1/6/2026$23.00Neutral → Buy
    BTIG Research
    Robinhood Markets Inc.
    $HOOD
    12/29/2025$145.00 → $135.00Buy
    Needham
    More analyst ratings

    $AVCT
    $AVYA
    $BBIG
    $BGRY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SaverOne and VisionWave Complete the First Stage of their Strategic Transaction to Advance an RF Defense Platform

    Initial $2.75 million investment completed as part of up to $7 million strategic transaction; Agreement includes RF technology collaboration expanding SaverOne's platform into defense and security markets Petah Tikvah, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd. (NASDAQ:SVRE, TASE: SVRE)), a technology company specializing in advanced transportation safety and RF-based solutions, today announced the completion of the first stage in its strategic transaction with VisionWave Holdings, Inc. (NASDAQ:VWAV), a multi-domain technology company building next-generation autonomous robotics, RF imaging, and AI-driven sensing. The completion of the first stage marks the formal lau

    3/10/26 8:30:00 AM ET
    $SVRE
    $VWAV
    EDP Services
    Technology
    Computer Software: Prepackaged Software

    Cadillac Formula 1® Team Joins Forces with Core Scientific as Official Data Center Partner

    Core Scientific and Cadillac Formula 1® Team Announce a Multi-Year Global Partnership Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or the "Company"), a leader in digital infrastructure for high-density colocation, and Cadillac Formula 1® Team have announced a multi-year global partnership, naming Core Scientific as the team's Official Data Center Partner. Core Scientific will play a central role in advising and shaping the team's data center infrastructure in its new U.S. headquarters, currently under construction in Indianapolis, Indiana. Through this partnership, Core Scientific will provide strategic consulting, architectural guidance and optimization expertise to ensure th

    3/10/26 8:00:00 AM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Robinhood Ventures Fund I (RVI) Announces Pricing of Initial Public Offering

    MENLO PARK, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Today, Robinhood Ventures Fund I (RVI) announced the pricing of its initial public offering of 12,615,608 common shares of beneficial interest at an initial public offering price of $25.00 per share, bringing the total size of the Fund to $658.4 million (or up to $705.7 million if the underwriter's option to purchase additional common shares is exercised in full.) The total fund size is calculated before deducting the sales load and offering expenses. All of the shares are being offered by RVI. The shares are expected to begin trading on the New York Stock Exchange (NYSE) on March 6, 2026 under the symbol RVI, and the offering is exp

    3/6/26 6:00:00 AM ET
    $HOOD
    Investment Bankers/Brokers/Service
    Finance

    $AVCT
    $AVYA
    $BBIG
    $BGRY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by SaverOne 2014 Ltd.

    3 - SaverOne 2014 Ltd. (0001894693) (Issuer)

    3/10/26 6:13:08 PM ET
    $SVRE
    EDP Services
    Technology

    Director Weiss Eric Stanton bought $101,700 worth of shares (7,000 units at $14.53), increasing direct ownership by 3% to 252,262 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    3/10/26 4:08:53 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Chief Technology Officer Pinner Jeffrey Tsvi sold $469,822 worth of shares (5,836 units at $80.50), decreasing direct ownership by 16% to 29,676 units (SEC Form 4)

    4 - Robinhood Markets, Inc. (0001783879) (Issuer)

    3/9/26 4:31:13 PM ET
    $HOOD
    Investment Bankers/Brokers/Service
    Finance

    $AVCT
    $AVYA
    $BBIG
    $BGRY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ladenburg Thalmann initiated coverage on Inhibikase Therapeutics with a new price target

    Ladenburg Thalmann initiated coverage of Inhibikase Therapeutics with a rating of Buy and set a new price target of $4.00

    3/4/26 8:37:45 AM ET
    $IKT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Core Scientific upgraded by Needham with a new price target

    Needham upgraded Core Scientific from Hold to Buy and set a new price target of $23.00

    3/3/26 10:31:14 AM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Needham reiterated coverage on Robinhood Markets with a new price target

    Needham reiterated coverage of Robinhood Markets with a rating of Buy and set a new price target of $100.00 from $135.00 previously

    2/11/26 7:05:02 AM ET
    $HOOD
    Investment Bankers/Brokers/Service
    Finance

    $AVCT
    $AVYA
    $BBIG
    $BGRY
    Leadership Updates

    Live Leadership Updates

    View All

    The $185B Cancer Surge: Why the FDA's Fast-Track Pivot is Scaling a New Immunotherapy Era

    VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary – The global immuno-oncology market is set to explode from its current $35 billion level to a massive $185.69 billion by 2035 as the industry moves toward the coordinated activation of the immune system[1]. This surge is being accelerated by the $69.16 billion genomics revolution, which is now integrating advanced profiling into every oncology workflow to pick winning treatments[2]. This strategic push for registration-ready precision assets fuels the 2026 investment case for Oncolytics Biotech Inc. (NASDAQ:ONCY), ImmunityBio (NASDAQ:IBRX), OS Therapies (NYSE-A: OSTX), BioNTech SE (NASDAQ:BNTX),

    1/14/26 10:39:59 AM ET
    $BNTX
    $CMPX
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    BluSky AI Inc. Appoints Riley Cooney as Corporate Development and Strategy Officer

    Salt Lake City Utah, Dec. 09, 2025 (GLOBE NEWSWIRE) -- BluSky AI Inc. (OTCID: BSAI), a leading developer of prefabricated modular AI infrastructure and Neocloud GPU-as-a-Service infrastructure, proudly announces the appointment of Riley Cooney as its Corporate Development and Strategy Officer. Cooney is a well-respected FP&A and strategic finance executive whose experience includes leadership through a $4B IPO in BTC and Hyperscale infrastructure. Riley has advised on AI and HPC data-center strategy, serving global institutional and Wall Street clients over the past two years. During his five years at Core Scientific (NASDAQ:CORZ), Riley helped scale revenue 24× while growing power capaci

    12/9/25 1:37:56 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Two Seas Capital Expresses Enthusiasm for Core Scientific's Future Prospects

    Issues Letter to Shareholders Highlighting Significant Upside Potential If Proposed Sale to CoreWeave Is Not Approved Urges Shareholders to Vote AGAINST the Ill-Advised Transaction on the GOLD Proxy Card Ahead of October 30, 2025 Special Meeting NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and one of the largest shareholders of Core Scientific, Inc. ("Core Scientific" or the "Company") (NASDAQ:CORZ), today issued a letter to shareholders in connection with its opposition to the Company's proposed sale to CoreWeave, Inc. ("CoreWeave") (NASDAQ:CRWV) on the terms announced on July 7, 2025.

    10/28/25 8:30:00 AM ET
    $CORZ
    $CRWV
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    $AVCT
    $AVYA
    $BBIG
    $BGRY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Weiss Eric Stanton bought $101,700 worth of shares (7,000 units at $14.53), increasing direct ownership by 3% to 252,262 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    3/10/26 4:08:53 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Director Hanish Arnold C bought $3,740 worth of shares (5,000 units at $0.75) (SEC Form 4)

    4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)

    11/24/25 5:08:13 PM ET
    $SLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Sands Capital Life Sciences Pulse Fund Ii, L.P. bought $2,999,999 worth of shares (2,068,965 units at $1.45) (SEC Form 4)

    4 - Inhibikase Therapeutics, Inc. (0001750149) (Issuer)

    11/24/25 3:47:02 PM ET
    $IKT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AVCT
    $AVYA
    $BBIG
    $BGRY
    SEC Filings

    View All

    SEC Form 6-K filed by SaverOne 2014 Ltd.

    6-K - SaverOne 2014 Ltd. (0001894693) (Filer)

    3/10/26 8:34:58 AM ET
    $SVRE
    EDP Services
    Technology

    Core Scientific Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - Core Scientific, Inc./tx (0001839341) (Filer)

    3/6/26 4:13:50 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    SEC Form EFFECT filed by Forge Global Holdings Inc.

    EFFECT - Forge Global Holdings, Inc. (0001827821) (Filer)

    3/6/26 12:15:03 AM ET
    $FRGE
    Investment Bankers/Brokers/Service
    Finance

    $AVCT
    $AVYA
    $BBIG
    $BGRY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by The OLB Group Inc.

    SC 13G/A - OLB GROUP, INC. (0001314196) (Subject)

    11/14/24 5:17:38 PM ET
    $OLB
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Salarius Pharmaceuticals Inc.

    SC 13G/A - Salarius Pharmaceuticals, Inc. (0001615219) (Subject)

    11/14/24 4:38:31 PM ET
    $SLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Inhibikase Therapeutics Inc.

    SC 13G - Inhibikase Therapeutics, Inc. (0001750149) (Subject)

    11/14/24 3:31:08 PM ET
    $IKT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AVCT
    $AVYA
    $BBIG
    $BGRY
    Financials

    Live finance-specific insights

    View All

    Core Scientific Announces Fourth Quarter Fiscal Year 2025 Results

    Key Highlights New Top-market Site: Announced an agreement to expand into Hunt County, Texas, which is expected to support ~430 MW of gross power capacity, with an approved ERCOT interconnection ramp schedule. Power Expansion at Existing Locations: Increased gross power capacity by ~300 MW across Dalton, Georgia and Pecos, Texas. Continued Execution on CoreWeave Contract: To date, energized ~350 MW of power and remain on track to deliver ~590 MW by early 2027. Core Scientific, Inc. (NASDAQ:CORZ), a leader in digital infrastructure for high-density colocation services, today announced financial results for the fourth quarter of 2025. "We're now past the halfway point on our e

    3/2/26 4:10:00 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Yatsen Announces Fourth Quarter and Full Year 2025 Financial Results

    Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on March 2, 2026GUANGZHOU, China, March 2, 2026 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE:YSG), a leading China-based beauty group, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Full Year 2025 HighlightsTotal net revenues for the fourth quarter of 2025 increased by 20.1% to RMB1.38 billion (US$197.3 million) from RMB1.15 billion for the prior year period. Total net revenues for the full year of 2025 increased by 26.7% to RMB4.30 billion (US$614.6 million) from RMB3.39 billion for the prior year period.Total net revenues fr

    3/2/26 5:00:00 AM ET
    $YSG
    Package Goods/Cosmetics
    Consumer Discretionary

    ImmunityBio to Provide a Business Update and Review Financial Results for FY 2025 on Tuesday, March 3, 2026

    ImmunityBio, Inc. ((IBRX), today announced that it will host a live conference call at 1:30 p.m. Pacific Time on Tuesday, March 3, 2026, to provide a business update, including progress across the company's clinical trial pipeline, and to review financial results for the year ended December 31, 2025. Conference Call Details The conference call will begin at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Tuesday, March 3, 2026. Interested parties may access the conference call through our Investor Relations website, ir.immunitybio.com, under Company — Events & Presentations. Alternatively, individuals can access the call by dialing 1-844-539-3703 or 1-412-652-1273 (internationally).

    2/27/26 7:30:00 AM ET
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care